306
Participants
Start Date
May 5, 2025
Primary Completion Date
June 5, 2026
Study Completion Date
August 1, 2028
DOR/3TC/TDF
It is a triple-drug antiretroviral drug co-formulated in a single tablet. It contains Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100/300/300 mg
BIC/FTC/TAF
It is a triple-drug antiretroviral drug co-formulated in a single tablet. It contains bictegravir 50 mg, tenofovir alafenamide 25 mg, and emtricitabine 200 mg. It is the standard therapy.
RECRUITING
Hospital de infectología, Centro Médico Nacional La Raza, Mexico City
Instituto Mexicano del Seguro Social
OTHER_GOV
José Antonio Mata Marín
OTHER_GOV